His main research concerns Immunology, Virology, Acquired immunodeficiency syndrome, Viral load and Lentivirus. Christopher D. Pilcher has included themes like Blood plasma and Sexual transmission in his Immunology study. His research investigates the connection with Virology and areas like Antibody which intersect with concerns in Nucleic acid amplification technique, Nucleic acid and Contact tracing.
The various areas that Christopher D. Pilcher examines in his Acquired immunodeficiency syndrome study include Viral disease and Medical physics. As a part of the same scientific family, Christopher D. Pilcher mostly works in the field of Viral load, focusing on Chronic infection and, on occasion, Mutation, Genotyping and Drug resistance. His research integrates issues of Internal medicine and Sida in his study of Lentivirus.
Christopher D. Pilcher mainly investigates Immunology, Virology, Viral load, Acquired immunodeficiency syndrome and Internal medicine. His Immunology study integrates concerns from other disciplines, such as Epidemiology and Sexual transmission. His Virology research also works with subjects such as
The concepts of his Viral load study are interwoven with issues in RNA and Viral shedding. His research in Acquired immunodeficiency syndrome intersects with topics in Viral disease and Transmission. In his research on the topic of Internal medicine, Zidovudine is strongly related with Efavirenz.
Incidence, Virology, Pediatrics, Transcriptome and Hiv incidence are his primary areas of study. His work in Incidence covers topics such as Reproducibility which are related to areas like Veterinary medicine. His Virology research incorporates themes from Antibody and Antiretroviral treatment.
The study incorporates disciplines such as Chronic infection and Gene in addition to Antibody. His Hiv incidence research is multidisciplinary, incorporating perspectives in Pathogen, Pol genes, Blood draw, Mutation detection and Drug resistance. Within one scientific family, Christopher D. Pilcher focuses on topics pertaining to Transmission under Seroconversion, and may sometimes address concerns connected to Acquired immunodeficiency syndrome, Recombinant DNA, Hiv 1 p24, Adverse effect and Confidence interval.
His primary scientific interests are in Pediatrics, Estimation, Machine learning, Test and Interval. His biological study spans a wide range of topics, including Hiv test, Hiv testing, Viral suppression and Retrospective analysis. Among his Estimation studies, you can observe a synthesis of other disciplines of science such as Artificial intelligence, Infection time, Research studies, Epidemiology and Point estimation.
His Machine learning research incorporates elements of Diagnostic test and Open source.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Brief but efficient: acute HIV infection and the sexual transmission of HIV.
Christopher D. Pilcher;Hsiao Chuan Tien;Joseph J. Eron;Pietro L. Vernazza.
The Journal of Infectious Diseases (2004)
Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection
Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten.
The New England Journal of Medicine (2004)
Detection of acute infections during HIV testing in North Carolina.
Christopher D. Pilcher;Susan A. Fiscus;Trang Q. Nguyen;Evelyn Foust.
The New England Journal of Medicine (2005)
Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection.
Christopher D. Pilcher;George Joaki;Irving F. Hoffman;Francis E.A. Martinson.
AIDS (2007)
Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size
Vivek Jain;Wendy Hartogensis;Peter Bacchetti;Peter W. Hunt.
The Journal of Infectious Diseases (2013)
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
Steven A. Yukl;Eli Boritz;Michael Busch;Christopher Bentsen.
PLOS Pathogens (2013)
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.
Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Christina Lalama.
JAMA (2006)
Acute HIV revisited: new opportunities for treatment and prevention
Christopher D. Pilcher;Joseph J. Eron;Shannon Galvin.
Journal of Clinical Investigation (2004)
Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.
Christopher D. Pilcher;J. Todd McPherson;Peter A. Leone;Marlene Smurzynski.
JAMA (2002)
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health.
Christopher D. Pilcher;Diane C. Shugars;Susan A. Fiscus;William C. Miller.
AIDS (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of North Carolina at Chapel Hill
University of California, San Francisco
University of North Carolina at Chapel Hill
University of California, San Francisco
University of North Carolina at Chapel Hill
Universidade de São Paulo
The Ohio State University
Technical University of Munich
University of Huddersfield
Colorado State University
University of Illinois at Chicago
Nichia Corporation (Japan)
Kyoto University
University of Science and Technology of China
Colorado State University
University of Strasbourg
Discovery Institute
Geological Survey of Israel
University of Washington
University of Nottingham
University of California, San Diego
Nanjing University
Swarthmore College